CytRx Corporation (CYTR)
|
2.15
0.00 (0.00%)
|
|
|
|
CYTR additional information
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.
CYTR Profile
•
Exchange
NASDAQ
•
Held by these Mutual Funds
Vanguard Extended Market Idx
iShares Russell 2000 Growth Index
Bridgeway Ultra-Small Company Market
Fidelity Spartan Extended Mkt Index Inv
iShares Russell Microcap Index
TFS Market Neutral
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Fidelity Spartan Total Market Index Inv
Vanguard Balanced Index
T. Rowe Price Total Equity Market Idx
iShares Russell 2000 Growth Index
Bridgeway Ultra-Small Company Market
Fidelity Spartan Extended Mkt Index Inv
iShares Russell Microcap Index
TFS Market Neutral
Vanguard Instl Ttl Stk Mkt Idx InstlPlus
Fidelity Spartan Total Market Index Inv
Vanguard Balanced Index
T. Rowe Price Total Equity Market Idx
•
Competitors
•
Executives
Mr. Steven A. Kriegsman
Chief Exec. Officer
Pres and Director
Mr. John Y. Caloz
Chief Financial Officer
Chief Accounting Officer and Treasurer
Mr. Benjamin S. Levin
VP of Legal Affairs
Corp. Sec. and Gen. Counsel
Dr. D. Scott Wieland Ph.D. B.A.
53
Sr. VP of Drug Devel.
Dr. Daniel Levitt M.D. .D.
64
Chief Medical Officer
Chief Exec. Officer
Pres and Director
Mr. John Y. Caloz
Chief Financial Officer
Chief Accounting Officer and Treasurer
Mr. Benjamin S. Levin
VP of Legal Affairs
Corp. Sec. and Gen. Counsel
Dr. D. Scott Wieland Ph.D. B.A.
53
Sr. VP of Drug Devel.
Dr. Daniel Levitt M.D. .D.
64
Chief Medical Officer
•
Employee Count
15
Special Offers
Competitors
CYTR earnings
Date
Actual
Expected
Prev Yr Qtr
8/9/2012
-0.63
-0.30
-0.21
5/10/2012
-0.07
-0.05
-0.07
3/13/2012
-0.03
-0.04
0.04
